IMMUNEBRIDGE
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Jan 2025)
What this means for you
This application is over — abandoned 20 Jan 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97435706
- Mark type
- Stylized text
- Filed
- 31 May 2022
- Published for opposition
- 25 Apr 2023
- Abandoned
- 20 Jan 2025
- Attorney of record
- Susan Neuberger Weller
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical, biologic, and stem cell products for therapies for the treatment of cancer
- Class 042 — Scientific and technological services: clinical trials for others in the field of immunotherapies for the treatment of cancer
Owner
- Immunebridge Inc., San Francisco, CA, US
- Immunebridge Inc., San Francisco, CA, US
Prosecution history
- 20 Jan 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Jan 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Apr 2024 — SOU EXTENSION 2 GRANTED
- 19 Apr 2024 — SOU EXTENSION 2 FILED
- 19 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Dec 2023 — SOU EXTENSION 1 GRANTED
- 04 Dec 2023 — SOU EXTENSION 1 FILED
- 04 Dec 2023 — SOU TEAS EXTENSION RECEIVED
- 20 Jun 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Apr 2023 — PUBLISHED FOR OPPOSITION
- 05 Apr 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Mar 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER